Comparison of topical tobramycin—dexamethasone with dexamethasone—neomycin—polymyxin and neomycin—polymyxin—gramicidin for control of inflammation after cataract surgery: Results of a multicenter, prospective, three-arm, randomized, double-masked, controlled, parallel-group study

• Published in: Clinical therapeutics 2004-08, Vol.26 (8), p.1274-1285
• Main Authors: Notivol, Ricardo, Bertin, Donata, Amin, Dina, Whitling, Anna, Kennedy, Margaret, Cockrum, Paul C.
• Format: Article
• Language: English
• Subjects: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - therapeutic use; Anti-Inflammatory Agents - administration & dosage; Anti-Inflammatory Agents - therapeutic use; Antibiotics; Biological and medical sciences; Brazil; Cataract Extraction; cataract surgery; Cataracts; Dexamethasone - administration & dosage; Dexamethasone - therapeutic use; dexamethasone-neomycin-polymyxin B combination; Double-Blind Method; Drug Therapy, Combination; Europe; Eye surgery; Female; Gramicidin - administration & dosage; Gramicidin - therapeutic use; Humans; Inflammation; Inflammation - pathology; Inflammation - prevention & control; Intraocular lenses; Male; Medical sciences; Middle Aged; Neomycin - administration & dosage; Neomycin - therapeutic use; Nonsteroidal anti-inflammatory drugs; ocular inflammation tobramycin-dexamethasone combination; Ophthalmology; phacoemulsification; Pharmacists; Pharmacology. Drug treatments; Polymyxins - administration & dosage; Polymyxins - therapeutic use; Postoperative Complications - pathology; Postoperative Complications - prevention & control; Prospective Studies; Sodium; Steroids; Tobramycin - administration & dosage; Tobramycin - therapeutic use; Treatment Outcome
• ISSN: 0149-2918; 1879-114X
• DOI: 10.1016/S0149-2918(04)80113-9

Intraocular inflammation is typically treated with a combination of anti-inflammatory and anti-infective drugs. Tobramycin—dexamethasone (TD) has not been associated with any serious adverse events, indicating good tolerability. The aims of this study were the following: (1) to demonstrate noninferiority of TD compared with dexamethasone—neomycin—polymyxin (DNP) in terms of anti-inflammatory efficacy, (2) to compare the anti-inflammatory efficacy of TD and DNP with that of a “placebo” control (antibiotic without anti-inflammatory agent), and (3) to provide additional safety data on TD. This prospective, double-masked, parallel-group study was conducted at 22 ophthalmology clinics across Europe and Brazil. Patients aged > 18 years undergoing cataract surgery were randomly assigned, in a 2: 2: 1 ratio, to receive tobramycin 3 mg/mL plus dexamethasone 1 mg/mL, dexamethasone 1 mg/mL plus neomycin sulfate 3500 IU/mL plus polymyxin B sulfate 6000 IU/mL, or neomycin sulfate 3500 IU/mL plus polymyxin B sulfate 7500 IU/mL plus gramicidin 20 μg/mL. All treatments were given as 1 drop instilled in the operated eye QID for 21 days. The primary efficacy end point, intraocular inflammation (determined using the sum of scores on anterior chamber cells and aqueous flare), was assessed at days 3, 8, 14, and 21 after surgery. A total of 271 patients were enrolled (158 women, 113 men; age range 42–90 years) (TD, 104 patients; DNP, 110 patients; and neomycin-polymyxin-gramicidin [NPG], 57 patients). Intraocular inflammation was similar in the TD and DNP groups at all time points. At days 8, 14, and 21, inflammation scores were significantly lower with TD than with NPG (all, P < 0.05). At day 8, the inflammation score was significantly lower with DNP than with NPG (P < 0.05). A greater number of patients receiving NPG experienced treatment-related ocular allergic reactions compared with patients receiving TD (P < 0.05). One patient receiving TD (1.0%) and 5 given NPG (9.0%) were withdrawn due to ocular allergic reactions. None of the patients experienced an increase in intraocular pressure ≥10 mm Hg from baseline. In this study of patients undergoing cataract surgery combination therapy with TD was noninferior to DNP and was well tolerated.